Protective Effect of Irsogladine on Monochloramine Induced Gastric Mucosal Lesions in Rats:a Comparative Study with Rebamipide

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2002 Jan 31

PMID 11819495

Citations 3

Authors

H Yamamoto

M Umeda

H Mizoguchi

S Kato

K Takeuchi

Affiliations

Soon will be listed here.

Abstract

AIM:To examine the effect of irsogladine, a novel antiulcer drug, on the mucosal ulcerogenic response to monochloramine (NH(2)Cl) in rat stomach, in comparison with rebamipide, another antiulcer drug with cytoprotective a ctivity.METHODS AND RESULTS:Oral administration of NH(2)Cl-(120mM) produced severe hemorrhagic lesions in unanesthetized rat stomachs.Both irsogladine (1mg/kg-10mg/ kg,po) and rebamipide (30mg/kg-100mg/kg, po) dose dependently prevented the development of these lesions in response to NH(2)Cl, the effect of irsogladine was significant at 3mg/kg or greater, and that of rebamipide only at 100mg/kg. The protective effect of irsogladine on NH(2)Cl induced gastric lesions was significantly reduced by N( G) nitro L arginine methyl ester (L-NAME) but not by indomethacin, while that of rebamipide was significantly mitigated by indomethacin but not by L-NAME. Topical application of NH(2)Cl-(20mM)caused a marked reduction of potential difference (PD) in exvivo stomachs. This PD reduction was not affected by mucosal application of irso-gladine, but significantly prevented by rebamipide. The mucosal exposure to NH(4)OH (120mM) also caused a marked PD reduction in the ischemic stomach (bleeding from the carotid artery), resulting in gastric lesions. These ulcerogenic and PD responses caused by NH(4)OH plus ischemia were also significantly mitigated by rebamipide, in an indomethacin sensitive manner, while irsogladine potently prevented such lesions without affecting the PD response, in a L-NAME sensitive manner.CONCLUSION:These results suggest that (1)NH(2)Cl gen-erated either exogenously or endogenously damages the gastric mucosa, (2)both irsogladine and rebamipide protect the stomach against injury caused by NH(2)Cl,and (3)the mechanism underlying the protective action of irsogladine is partly mediated by endogenous nitric oxide, while that of rebamipide is in part mediated by endogenous prostaglandins.

Citing Articles

Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.

Yao J, Zhu Y, Sun W, Sawada N, Hiramatsu N, Takeda M Br J Pharmacol. 2007; 151(4):457-66.

PMID: 17435794 PMC: 2013962. DOI: 10.1038/sj.bjp.0707255.

Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.

Hiratsuka T, Futagami S, Shindo T, Hamamoto T, Ueki N, Suzuki K Dig Dis Sci. 2005; 50 Suppl 1:S84-9.

PMID: 16184426 DOI: 10.1007/s10620-005-2811-6.

Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats.

Li L, Qu R, Wang W, Guo H World J Gastroenterol. 2003; 9(3):553-6.

PMID: 12632517 PMC: 4621581. DOI: 10.3748/wjg.v9.i3.553.

References

Nishiwaki H, Kato S, Takeuchi K . Irritant action of monochloramine in rat stomachs: effects of zinc L-carnosine (polaprezinc). Gen Pharmacol. 1997; 29(5):713-8. DOI: 10.1016/s0306-3623(97)00071-2. View

Whittle B, Lopez-Belmonte J, Moncada S . Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol. 1990; 99(3):607-11. PMC: 1917359. DOI: 10.1111/j.1476-5381.1990.tb12977.x. View

Badwey J, Karnovsky M . Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem. 1980; 49:695-726. DOI: 10.1146/annurev.bi.49.070180.003403. View

Murakami M, Saita H, Teramura S, Dekigai H, Asagoe K, Kusaka S . Gastric ammonia has a potent ulcerogenic action on the rat stomach. Gastroenterology. 1993; 105(6):1710-5. DOI: 10.1016/0016-5085(93)91067-r. View

Graham D . Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989; 96(2 Pt 2 Suppl):615-25. DOI: 10.1016/s0016-5085(89)80057-5. View

Ivey K, Denbesten L, CLIFTON J . Effect of bile salts on ionic movement across the human gastric mucosa. Gastroenterology. 1970; 59(5):683-90. View

Grisham M, Jefferson M, Melton D, Thomas E . Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem. 1984; 259(16):10404-13. View

Grisham M, Hernandez L, Granger D . Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986; 251(4 Pt 1):G567-74. DOI: 10.1152/ajpgi.1986.251.4.G567. View

Murakami M, Asagoe K, Dekigai H, Kusaka S, Saita H, Kita T . Products of neutrophil metabolism increase ammonia-induced gastric mucosal damage. Dig Dis Sci. 1995; 40(2):268-73. DOI: 10.1007/BF02065408. View

10.

Yoshikawa T, Naito Y, Tanigawa T, Kondo M . Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung. 1993; 43(3):363-6. View

11.

Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K . Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung. 1992; 42(12):1462-6. View

12.

Klebanoff S . Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med. 1980; 93(3):480-9. DOI: 10.7326/0003-4819-93-3-480. View

13.

Ueda F, ARATANI S, Mimura K, Kimura K, Nomura A, Enomoto H . Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals. Arzneimittelforschung. 1984; 34(4):474-7. View

14.

Marshall B, Langton S . Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet. 1986; 1(8487):965-6. DOI: 10.1016/s0140-6736(86)91060-3. View

15.

Takeuchi K, Ishihara Y, Okada M, Niida H, Okabe S . A continuous monitoring of mucosal integrity and secretory activity in rat stomach: a preparation using a lucite chamber. Jpn J Pharmacol. 1989; 49(2):235-44. DOI: 10.1254/jjp.49.235. View

16.

Tepperman B, Whittle B . Endogenous nitric oxide and sensory neuropeptides interact in the modulation of the rat gastric microcirculation. Br J Pharmacol. 1992; 105(1):171-5. PMC: 1908603. DOI: 10.1111/j.1476-5381.1992.tb14230.x. View

17.

Whitehead R, TRUELOVE S, Gear M . The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol. 1972; 25(1):1-11. PMC: 477213. DOI: 10.1136/jcp.25.1.1. View

18.

Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S . Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol. 1987; 142(1):23-9. DOI: 10.1016/0014-2999(87)90649-2. View

19.

Ueda F, ARATANI S, Mimura K, Kimura K, Nomura A, Enomoto H . Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal damage induced by various necrotizing agents in rats. Arzneimittelforschung. 1984; 34(4):478-84. View

20.

Kato S, Nishiwaki H, Konaka A, Takeuchi K . Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate. Dig Dis Sci. 1997; 42(10):2156-63. DOI: 10.1023/a:1018847324172. View